Karl H. Kurth

A Prospective European Organization for Research and Treatment of Cancer Genitourinary Group Randomized Trial Comparing Transurethral Resection Followed by a Single Intravesical Instillation of Epirubicin or Water in Single Stage Ta, T1 Papillary Carcinoma of the Bladder

Willem Oosterlinck, Karl H. Kurth, Fritz H. Schröder et al. · The Journal of Urology · 1993 · 367 citations

Medicine, Surgery, Urology +12

Identification of Patients With Prostate Cancer Who Benefit From Immediate Postoperative Radiotherapy: EORTC 22911

Theodorus van der Kwast, M. Bolla, Paul Van Cangh et al. · Journal of Clinical Oncology · 2007 · 291 citations · Full text

Medicine, Oncology, Surgery +17

Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic Value

Theo M. de Reijke, Elizabeth C. de Boer, Karl H. Kurth et al. · The Journal of Urology · 1996 · 182 citations

Medicine, Immunology, Oncology +17

BACILLUS CALMETTE-GUERIN VERSUS EPIRUBICIN FOR PRIMARY, SECONDARY OR CONCURRENT CARCINOMA IN SITU OF THE BLADDER: RESULTS OF A EUROPEAN ORGANIZATION FOR THE RESEARCH AND TREATMENT OF CANCER—GENITO-URINARY GROUP PHASE III TRIAL (30906)

Theo M. de Reijke, Karl H. Kurth, Richard Sylvester et al. · The Journal of Urology · 2005 · 123 citations

Medicine, Oncology, Urology +12

EARLY VERSUS DELAYED ENDOCRINE TREATMENT OF pN1-3 M0 PROSTATE CANCER WITHOUT LOCAL TREATMENT OF THE PRIMARY TUMOR: RESULTS OF EUROPEAN ORGANISATION FOR THE RESEARCH AND TREATMENT OF CANCER 30846—A PHASE III STUDY

Fritz H. Schröder, Karl H. Kurth, Sophie D. Fosså et al. · The Journal of Urology · 2004 · 100 citations

Medicine, Oncology, Surgery +17